1. Home
  2. PRPO vs SLE Comparison

PRPO vs SLE Comparison

Compare PRPO & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • SLE
  • Stock Information
  • Founded
  • PRPO N/A
  • SLE 2014
  • Country
  • PRPO United States
  • SLE United States
  • Employees
  • PRPO N/A
  • SLE N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • PRPO Industrials
  • SLE Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • SLE Nasdaq
  • Market Cap
  • PRPO 9.9M
  • SLE 8.6M
  • IPO Year
  • PRPO N/A
  • SLE 2019
  • Fundamental
  • Price
  • PRPO $6.65
  • SLE $0.55
  • Analyst Decision
  • PRPO
  • SLE Strong Buy
  • Analyst Count
  • PRPO 0
  • SLE 2
  • Target Price
  • PRPO N/A
  • SLE $2.50
  • AVG Volume (30 Days)
  • PRPO 6.8K
  • SLE 75.5K
  • Earning Date
  • PRPO 03-28-2025
  • SLE 03-26-2025
  • Dividend Yield
  • PRPO N/A
  • SLE N/A
  • EPS Growth
  • PRPO N/A
  • SLE N/A
  • EPS
  • PRPO N/A
  • SLE N/A
  • Revenue
  • PRPO $17,411,000.00
  • SLE $22,266,000.00
  • Revenue This Year
  • PRPO $75.18
  • SLE N/A
  • Revenue Next Year
  • PRPO N/A
  • SLE $33.97
  • P/E Ratio
  • PRPO N/A
  • SLE N/A
  • Revenue Growth
  • PRPO 31.31
  • SLE N/A
  • 52 Week Low
  • PRPO $4.31
  • SLE $0.50
  • 52 Week High
  • PRPO $7.20
  • SLE $2.84
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 63.80
  • SLE 42.25
  • Support Level
  • PRPO $6.52
  • SLE $0.51
  • Resistance Level
  • PRPO $6.90
  • SLE $0.65
  • Average True Range (ATR)
  • PRPO 0.27
  • SLE 0.05
  • MACD
  • PRPO 0.03
  • SLE -0.00
  • Stochastic Oscillator
  • PRPO 89.90
  • SLE 33.68

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn and create. The company offers a complete range of development, distribution, monetization and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising including immersive game world and experience publishing and in-game media products, direct to consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: